Citations

Showing 10 of 108119 citations.

Single-level awake transforaminal lumbar interbody fusion: a Mayo Clinic institutional experience and national analysis
Abode-Iyamah, Kingsley, Ghaith, Abdul Karim, Bhandarkar, Archis R., Biase, Gaetano De, Rajjoub, Rami, Chen, Selby G., Quiñones-Hinojosa, Alfredo, Bydon, Mohamad, Biase, Gaetano De , De Biase, Gaetano , Abode-Iyamah, Kingsley, Ghaith, Abdul Karim, Bhandarkar, Archis R., Rajjoub, Rami, Chen, Selby G., Quiñones-Hinojosa, Alfredo, Bydon, Mohamad

Mayo Clinic

Neurosurgical Focus | December 1, 2021 | Volume: 51 | Issue: 6 | Pages: E4

10.3171/2021.9.focus21457 | PMID 34852317 Get It

OBJECTIVE Awake transforaminal lumbar interbody fusion (TLIF) is a novel technique for performing spinal fusions in patients under conscious sedation. Whether awake TLIF can reduce operative times and decrease the hospital length of stay (LOS) remains to be shown. In this study, the authors sought to assess the differences in clinical outcomes between patients who underwent awake TLIF and those who underwent TLIF under general anesthesia by using institutional experience at the Mayo Clinic and the National Surgical Quality Improvement Program (NSQIP) database. METHODS Chart review was performed for a consecutive series of patients who underwent single-level minimally invasive surgery (MIS)–TLIF performed by a single surgeon (K.A.I.) at a single institution. Additionally, the NSQIP database was queried from 2016 to 2019 for patients who underwent awake TLIF as well as propensity score–matched patients who underwent TLIF under general anesthesia. RESULTS A total of 20 patients at Mayo Clinic underwent awake single-level MIS-TLIF. The mean operative time was 122 ± 16.68 minutes, and the mean estimated blood loss was 39 ± 30.24 ml. No intraoperative complications were reported. A total of 96 patients who underwent TLIF (24 awake and 72 under general anesthesia) were analyzed from the NSQIP database. The mean LOS was less in the awake cohort (1.4 ± 1.381 days) than the general anesthesia cohort (3 ± 2.274 days) (p = 0.002). CONCLUSIONS Evidence from the authors’ institutional experience and national analysis has demonstrated that awake MIS-TLIF is efficient and can reduce hospital LOS.
Spinal versus general anesthesia for minimally invasive transforaminal lumbar interbody fusion: implications on operating room time, pain, and ambulation
Biase, Gaetano De, Gruenbaum, Shaun E., West, James L., Chen, Selby, Bojaxhi, Elird, Kryzanski, James, Quiñones-Hinojosa, Alfredo, Abode-Iyamah, Kingsley, Biase, Gaetano De , De Biase, Gaetano , Gruenbaum, Shaun E., West, James L., Chen, Selby, Bojaxhi, Elird, Kryzanski, James, Quiñones-Hinojosa, Alfredo, Abode-Iyamah, Kingsley

Mayo Clinic

Neurosurgical Focus | December 1, 2021 | Volume: 51 | Issue: 6 | Pages: E3

10.3171/2021.9.focus21265 | PMID 34852316 Get It

OBJECTIVE There has been increasing interest in the use of spinal anesthesia (SA) for spine surgery, especially within Enhanced Recovery After Surgery (ERAS) protocols. Despite the wide adoption of SA by the orthopedic practices, it has not gained wide acceptance in lumbar spine surgery. Studies investigating SA versus general anesthesia (GA) in lumbar laminectomy and discectomy have found that SA reduces perioperative costs and leads to a reduction in analgesic use, as well as to shorter anesthesia and surgery time. The aim of this retrospective, case-control study was to compare the perioperative outcomes of patients who underwent minimally invasive surgery (MIS)–transforaminal lumbar interbody fusion (TLIF) after administration of SA with those who underwent MIS-TLIF under GA. METHODS Overall, 40 consecutive patients who underwent MIS-TLIF by a single surgeon were analyzed; 20 patients received SA and 20 patients received GA. Procedure time, intraoperative adverse events, postoperative adverse events, postoperative length of stay, 3-hour postanesthesia care unit (PACU) numeric rating scale (NRS) pain score, opioid medication, and time to first ambulation were collected for each patient. RESULTS The two groups were homogeneous for clinical characteristics. A decrease in total operating room (OR) time was found for patients who underwent MIS-TLIF after administration of SA, with a mean OR time of 156.5 ± 18.9 minutes versus 213.6 ± 47.4 minutes for patients who underwent MIS-TLIF under GA (p < 0.0001), a reduction of 27%. A decrease in total procedure time was also observed for SA versus GA (122 ± 16.7 minutes vs 175.2 ± 10 minutes; p < 0.0001). No significant differences were found in intraoperative and postoperative adverse events. There was a difference in the mean maximum NRS pain score during the first 3 hours in the PACU as patients who received SA reported a lower pain score compared with those who received GA (4.8 ± 3.5 vs 7.3 ± 2.7; p = 0.018). No significant difference was observed in morphine equivalents received by the two groups. A difference was also observed in the mean overall NRS pain score, with 2.4 ± 2.1 for the SA group versus 4.9 ± 2.3 for the GA group (p = 0.001). Patients who received SA had a shorter time to first ambulation compared with those who received GA (385.8 ± 353.8 minutes vs 855.9 ± 337.4 minutes; p < 0.0001). CONCLUSIONS The results of this study have pointed to some important observations in this patient population. SA offers unique advantages in comparison with GA for performing MIS-TLIF, including reduced OR time and postoperative pain, and faster postoperative mobilization.
Surgical Interventions During End-of-Life Hospitalizations in Children’s Hospitals
Antiel, Ryan M. , Camazine, Maraya , Blinman, Thane A. , Nance, Michael L. , Traynor, Michael D. , Camazine, Maraya N, Eghtesady, Pirooz , Lam, Sandi , Hall, Matt , Feudtner, Chris

Mayo Clinic

Pediatrics | December 1, 2021 | Volume: 148 | Issue: 6 | Pages: No page available

10.1542/peds.2020-047464 | PMID 34850192 Get It

OBJECTIVES To characterize patterns of surgery among pediatric patients during terminal hospitalizations in children’s hospitals. METHODS We reviewed patients ≤20 years of age who died among 4 424 886 hospitalizations from January 2013–December 2019 within 49 US children’s hospitals in the Pediatric Health Information System database. Surgical procedures, identified by International Classification of Diseases procedure codes, were classified by type and purpose. Descriptive statistics characterized procedures, and hypothesis testing determined if undergoing surgery varied by patient age, race and ethnicity, or the presence of chronic complex conditions (CCCs). RESULTS Among 33 693 terminal hospitalizations, the majority (n = 30 440, 90.3%) of children were admitted for nontraumatic causes. Of these children, 15 142 (49.7%) underwent surgery during the hospitalization, with the percentage declining over time (P &lt; .001). When surgical procedures were classified according to likely purpose, the most common were to insert or address hardware or catheters (31%), explore or aid in diagnosis (14%), attempt to rescue patient from mortality (13%), or obtain a biopsy (13%). Specific CCC types were associated with undergoing surgery. Surgery during terminal hospitalization was less likely among Hispanic children (47.8%; P &lt; .001), increasingly less likely as patient age increased, and more so for Black, Asian American, and Hispanic patients compared with white patients (P &lt; .001). CONCLUSIONS Nearly half of children undergo surgery during their terminal hospitalization, and accordingly, pediatric surgical care is an important aspect of end-of-life care in hospital settings. Differences observed across race and ethnicity categories of patients may reflect different preferences for and access to nonhospital-based palliative, hospice, and end-of-life care.
Dermatologic Manifestations of Systemic Diseases in Childhood
Quddusi, Fatima I., Youssef, Molly J. , Davis, Dawn Marie R. , Quddusi, Fatima I.

Mayo Clinic

Pediatrics In Review | December 1, 2021 | Volume: 42 | Issue: 12 | Pages: 655-671

10.1542/pir.2020-000679 | PMID 34850179 Get It

Safety of Immunizations for the Adult Patient With Inflammatory Bowel Disease—A Systematic Review and Meta-analysis
Desalermos, Athanasios , Pimienta, Michael , Shehadeh, Fadi , Karamanolis, George, Caldera, Freddy , Caldera, Freddy , Kalligeros, Markos , Diamantopoulos, Leonidas Nikolaos , Farraye, Francis A.

Mayo Clinic

Inflammatory Bowel Diseases | December 1, 2021 | Volume: 28 | Issue: 9 | Pages: 1430-1442

10.1093/ibd/izab266 | PMID 34849941 Get It

Abstract Background Patients with inflammatory bowel disease (IBD) have low vaccination rates for vaccine-preventable diseases. Fear of adverse reactions (AEs) appear to negatively affect vaccination efforts. We aimed to systemically review the risks for AEs following immunization for patients with IBD. Methods We searched PubMed and Embase until April 15, 2020, for studies evaluating the safety of vaccinations among patients with IBD. The primary outcome was the incidence of systemic and local AEs among vaccinated patients. Secondary outcome was the rate of IBD flare following immunization. We utilized a random effects meta-analysis of proportions using the DerSimonian-Laird approach to estimate the safety of immunizations. Results A total of 13 studies with 2116 patients was included in our analysis after fulfilling our inclusion criteria. Seven studies examined the influenza vaccine, 4 the pneumococcal vaccine, 1 the recombinant zoster vaccine, and 1 the hepatitis B vaccine. Follow-up of patients was up to 6 months. The majority of AEs were local, with a pooled incidence of 24% (95% CI, 9%-42%) for all vaccines. Systemic AEs were mostly mild, without resulting in hospitalizations or deaths, with a pooled incidence of 16% (95% CI, 6%-29%) for all vaccines. Flare of inflammatory bowel disease after vaccination found with a pooled incidence of 2% (95% CI, 1%-4%) and we include in the analysis data from all immunizations examined. Discussion Our study demonstrated that AEs after vaccination are mainly local or mildly systemic and do not differ significantly from the expected AE after recommended immunizations for the general population. Thus, gastroenterologists should reinforce that vaccines are safe in patients with IBD.
Enhanced Dopamine Sensitivity Using Steered Fast-Scan Cyclic Voltammetry
Kang, Yumin , Goyal, Abhinav , Hwang, Sangmun, Park, Cheonho , Cho, Hyun U., Shin, Hojin , Park, Jinsick , Bennet, Kevin E. , Lee, Kendall H. , Oh, Yoonbae , Jang, Dong Pyo , Oh, Yoonbae

Mayo Clinic

ACS Omega | December 1, 2021 | Volume: 6 | Issue: 49 | Pages: 33599-33606

10.1021/acsomega.1c04475 | PMID 34926907 Get It

Comparing reliability of ICD‐10‐based COVID‐19 comorbidity data to manual chart review, a retrospective cross‐sectional study
Schaefer, Joseph , Riley, Joshua M. , Li, Michael , Cheney-Peters, Dianna , Venkataraman, Chantel M., Li, Chris J. , Smaltz, Christa, Bradley, Conor G., Lee, Crystal Y., Fitzpatrick, Danielle M., Ney, David B., Zaret, Dina, Chalikonda, Divya, Mairose, Joshua D., Chauhan, Kashyap , Szot, Margaret V., Jones, Robert B. , Bashir‐Hamidu, Rukaiya, Mitsuhashi, Shuji , Kubey, Alan , Kubey, Alan A

Mayo Clinic

Journal of Medical Virology | December 1, 2021 | Volume: 94 | Issue: 4 | Pages: 1550-1557

10.1002/jmv.27492 | PMID 34850420 Get It

AbstractInternational Statistical Classification of Disease and Related Health Problems, 10th Revision codes (ICD‐10) are used to characterize cohort comorbidities. Recent literature does not demonstrate standardized extraction methods. Objective: Compare COVID‐19 cohort manual‐chart‐review and ICD‐10‐based comorbidity data; characterize the accuracy of different methods of extracting ICD‐10‐code‐based comorbidity, including the temporal accuracy with respect to critical time points such as day of admission. Design: Retrospective cross‐sectional study. Measurements: ICD‐10‐based‐data performance characteristics relative to manual‐chart‐review. Results: Discharge billing diagnoses had a sensitivity of 0.82 (95% confidence interval [CI]: 0.79–0.85; comorbidity range: 0.35–0.96). The past medical history table had a sensitivity of 0.72 (95% CI: 0.69–0.76; range: 0.44–0.87). The active problem list had a sensitivity of 0.67 (95% CI: 0.63–0.71; range: 0.47–0.71). On day of admission, the active problem list had a sensitivity of 0.58 (95% CI: 0.54–0.63; range: 0.30–0.68)and past medical history table had a sensitivity of 0.48 (95% CI: 0.43–0.53; range: 0.30–0.56). Conclusions and Relevance: ICD‐10‐based comorbidity data performance varies depending on comorbidity, data source, and time of retrieval; there are notable opportunities for improvement. Future researchers should clearly outline comorbidity data source and validate against manual‐chart‐review.
Anesthetic Considerations for Patients on Psychotropic Drug Therapies
Harbell, Monica W. , Dumitrascu, Catalina , Bettini, Layne M., Thiele, Cameron M., Koyyalamudi, Veerandra , Bettini, Layne, Yu, Soojie , Harbell, Monica W , Dumitrascu, Catalina

Mayo Clinic

Neurology International | December 1, 2021 | Volume: 13 | Issue: 4 | Pages: 640-658

10.3390/neurolint13040062 | PMID 34940748 Get It

Psychotropic drugs are used in the treatment of psychiatric and non-psychiatric conditions. Many patients who are on psychotropic medications may present for procedures requiring anesthesia. Psychotropic medications can have dangerous interactions with drugs commonly used in anesthesia, some of which can be life-threatening. In this review, we describe the current anesthetic considerations for patients on psychotropic drug therapies, including antidepressants, antipsychotics, mood stabilizers, anxiolytics, and stimulants. The pharmacology, side effects, and potential drug interactions of the commonly prescribed psychotropic drug therapies with anesthetic agents are described. Further, we highlight the current recommendations regarding the cessation and continuation of these medications during the perioperative period.
EPPOCRATIS: A Point-of-Care Utilization of Virtual Surgical Planning and Three-Dimensional Printing for the Management of Acute Craniomaxillofacial Trauma
Sharaf, Basel , Kuruoglu, Doga , Sharaf, Basel A, Kuruoglu, Doga , Sharaf, Basel A , Morris, Jonathan M.

Mayo Clinic

Journal of Clinical Medicine | December 1, 2021 | Volume: 10 | Issue: 23 | Pages: 5640

10.3390/jcm10235640 | PMID 34884342 Get It

While virtual surgical planning (VSP) and three-dimensional planning (3DP) have become important tools in acute craniomaxillofacial surgery, the incorporation of point of care VSP and 3DP is crucial to allow for acute facial trauma care. In this article, we review our approach to acute craniomaxillofacial trauma management, EPPOCRATIS, and discuss current challenges and future directions in acute facial trauma management.